| Financial Year |
March 31 2023 |
| Monetary Funds |
577,090,590.15 |
| Held-for-trading Financial Assets |
11,470,373.76 |
| Notes Receivable |
1,800,000.00 |
| Accounts Receivable |
30,452,155.47 |
| Advances to Suppliers |
427,863,653.53 |
| Other Receivables |
42,777,211.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,715,063.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,761,518.06 |
| Total Current Assets |
1,105,930,566.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
339,937,577.07 |
| Investment Properties |
226,958,989.08 |
| Fixed Assetes |
1,281,047,011.35 |
| Under-construction Projects |
134,981,401.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,175,714.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,637,147.45 |
| Deferred Income Tax Assets |
318,024.64 |
| Other Non-Current Assets |
81,150,575.56 |
| Sub-Total of Non-Current Assets |
2,219,076,469.90 |
| Total Assets |
3,325,007,036.19 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
56,361,090.68 |
| Accounts Received In Advance |
34,432,118.91 |
| Employee Compensation Payable |
21,476,680.66 |
| Taxes Payable |
2,572,005.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,670,113.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
67,165.33 |
| Other Current Liabilities |
862,214.18 |
| Sub-Total of Current Liabilities |
136,177,895.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,470,976.37 |
| Total Liabilities |
139,648,871.54 |
| Paid-In Capital(Or Share Stock) |
464,158,282.00 |
| Capital Surplus |
2,134,614,669.57 |
| Surplus Reserve |
79,446,439.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
463,855,783.38 |
| Minority Stockholder's Interest |
41,177,230.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,144,180,934.30 |
| Owner's Equity（Stockholder's Equity） |
3,185,358,164.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,325,007,036.19 |
